Liposomes are a popular and effective type of nanomaterial for drug delivery, known for their biocompatibility, low toxicity, and ability to encapsulate both hydrophilic and hydrophobic molecules. CD Formulation has extensive expertise and many years of experience in providing specialized liposome drug delivery system development, offering tailored solutions for diverse research applications.
Liposomes are spherical vesicles composed of phospholipid bilayers that can encapsulate a range of drugs, including anticancer agents, antibiotics, siRNA, antisense oligonucleotides, and therapeutic genes. Their structure mimics cell membranes, allowing for efficient drug delivery and extended circulation time.
Fig.1 Schematic presentation of the structure of a typical liposome. (Abbasi H, et al, 2023)
Liposome-based drug delivery utilizes two main mechanisms: passive targeting, which leverages the enhanced permeability and retention (EPR) effect, and active targeting, which involves surface modifications to improve drug specificity and reduce toxicity.
Fig.2 Schematic illustration of the mechanism of passive targeting and active targeting. (Abbasi H, et al, 2023)
Liposomes are ideal for delivering chemotherapy drugs due to their ability to concentrate at tumor sites while minimizing side effects. We offer a range of solutions, including long-circulating, active-targeting, stimulus-responsive, and cell membrane-coated liposomes to accelerate cancer treatment research.
Researchers are delving deeper into the transmission of genetic material through liposomes; however, the interaction between liposomes and cells remains enigmatic. Liposome-mediated genetic material transfer can face systemic barriers, such as lysosomal degradation, endosomal escape, and nuclear uptake. Therefore, we are committed to assisting our clients in controlling the physical structure and chemical properties of liposomes to ensure successful gene delivery.
Liposomes, bubble-like lipid bilayer structures ranging in size from nanometers to microns, show great promise as carriers for antigens in various delivery systems. Although currently there are limited numbers of liposome vaccines, their use offers the following advantages: protecting the antigen from degradation, carrying both hydrophilic and lipophilic antigens, controlling the release of antigens, enhancing cell uptake, and improving immune responses to specific antigens. By adjusting properties such as size, charge, membrane fluidity, and surface modification, we can optimize targeted delivery of liposomes to specific cells.
The latest advancements in liposome carrier technology present a promising opportunity to surmount the challenge of ocular drug delivery, with improved permeability, enhanced retention, heightened solubility, reduced toxicity, prolonged release time, and targeted drug delivery to the eyes. By examining various ocular drug delivery systems in conjunction with the specific characteristics of the drug, our objective is to assist our clients in developing superior ocular delivery systems.
Techniques & Platforms | Details |
Liposome Delivery System Development Platform |
|
Characterization Platform |
|
As a leader in nanoparticles, CD Formulation is committed to developing professional liposome delivery systems and superior liposome products. Please do not hesitate to contact us if you require any assistance.
References